eFFECTOR Therapeutics Inc
F:LWK1
eFFECTOR Therapeutics Inc
F:LWK1
Price:
9.1
EUR
Market Cap:
€1.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
eFFECTOR Therapeutics Inc
F:LWK1
|
US |
|
S
|
SWS Hemodialysis Care Co Ltd
SSE:688410
|
CN |
|
Health House International Ltd
ASX:HHI
|
AU |
|
Encavis AG
LSE:0NBT
|
DE |
|
Pc Partner Group Ltd
HKEX:1263
|
HK |
|
HK Electric Investments Ltd
OTC:HKVTY
|
HK |
|
A
|
Atour Lifestyle Holdings Ltd
NASDAQ:ATAT
|
CN |
|
Indian Oil Corporation Ltd
NSE:IOC
|
IN |
|
G
|
Goldstorm Metals Corp
XTSX:GSTM
|
CA |
|
Z
|
Zincore Metals Inc
OTC:ZCRMF
|
CA |
|
Y
|
Yuanda China Holdings Ltd
HKEX:2789
|
CN |
|
Cimbeton Hazirbeton ve Prefabrik Yapi Elemanlari Sanayi ve Ticaret AS
IST:CMBTN.E
|
TR |
|
Horizon Gold Ltd
ASX:HRN
|
AU |
|
Federal Bank Ltd
NSE:FEDERALBNK
|
IN |
|
ACV Auctions Inc
NYSE:ACVA
|
US |
|
V
|
Vaisala Oyj
OMXH:VAIAS
|
FI |
|
F
|
Fixer Inc
TSE:5129
|
JP |
Balance Sheet
Balance Sheet Decomposition
eFFECTOR Therapeutics Inc
eFFECTOR Therapeutics Inc
Balance Sheet Decomposition is not available for
eFFECTOR Therapeutics Inc
eFFECTOR Therapeutics Inc
Balance Sheet
eFFECTOR Therapeutics Inc
eFFECTOR Therapeutics Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
3
|
15
|
50
|
9
|
15
|
|
| Cash Equivalents |
3
|
15
|
50
|
9
|
15
|
|
| Short-Term Investments |
0
|
0
|
0
|
18
|
3
|
|
| Other Current Assets |
1
|
1
|
3
|
2
|
1
|
|
| Total Current Assets |
4
|
17
|
53
|
28
|
20
|
|
| PP&E Net |
1
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
1
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
3
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
1
|
1
|
|
| Total Assets |
5
N/A
|
17
+228%
|
54
+224%
|
29
-46%
|
21
-29%
|
|
| Liabilities | ||||||
| Accounts Payable |
1
|
0
|
1
|
1
|
2
|
|
| Accrued Liabilities |
3
|
2
|
3
|
4
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
15
|
6
|
0
|
19
|
19
|
|
| Other Current Liabilities |
0
|
1
|
0
|
0
|
0
|
|
| Total Current Liabilities |
19
|
9
|
4
|
25
|
26
|
|
| Long-Term Debt |
0
|
7
|
19
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
14
|
0
|
1
|
|
| Total Liabilities |
19
N/A
|
16
-17%
|
37
+134%
|
25
-32%
|
26
+5%
|
|
| Equity | ||||||
| Common Stock |
133
|
133
|
0
|
0
|
0
|
|
| Retained Earnings |
151
|
137
|
121
|
144
|
179
|
|
| Additional Paid In Capital |
4
|
4
|
138
|
147
|
174
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
14
N/A
|
1
N/A
|
17
+1 665%
|
4
-77%
|
6
N/A
|
|
| Total Liabilities & Equity |
5
N/A
|
17
+228%
|
54
+224%
|
29
-46%
|
21
-29%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
3
|
|
Switch to:
Switch to:
See Also
Discover More
